Cargando…

A systematic analysis of UK cancer research funding by gender of primary investigator

OBJECTIVES: To categorically describe cancer research funding in the UK by gender of primary investigator (PIs). DESIGN: Systematic analysis of all open-access data. METHODS: Data about public and philanthropic cancer research funding awarded to UK institutions between 2000 and 2013 were obtained fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Charlie D, Head, Michael G, Marshall, Dominic C, Gilbert, Barnabas J, El-Harasis, Majd A, Raine, Rosalind, O’Connor, Henrietta, Atun, Rifat, Maruthappu, Mahiben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931297/
https://www.ncbi.nlm.nih.gov/pubmed/29712689
http://dx.doi.org/10.1136/bmjopen-2017-018625
_version_ 1783319624403648512
author Zhou, Charlie D
Head, Michael G
Marshall, Dominic C
Gilbert, Barnabas J
El-Harasis, Majd A
Raine, Rosalind
O’Connor, Henrietta
Atun, Rifat
Maruthappu, Mahiben
author_facet Zhou, Charlie D
Head, Michael G
Marshall, Dominic C
Gilbert, Barnabas J
El-Harasis, Majd A
Raine, Rosalind
O’Connor, Henrietta
Atun, Rifat
Maruthappu, Mahiben
author_sort Zhou, Charlie D
collection PubMed
description OBJECTIVES: To categorically describe cancer research funding in the UK by gender of primary investigator (PIs). DESIGN: Systematic analysis of all open-access data. METHODS: Data about public and philanthropic cancer research funding awarded to UK institutions between 2000 and 2013 were obtained from several sources. Fold differences were used to compare total investment, award number, mean and median award value between male and female PIs. Mann-Whitney U tests were performed to determine statistically significant associations between PI gender and median grant value. RESULTS: Of the studies included in our analysis, 2890 (69%) grants with a total value of £1.82 billion (78%) were awarded to male PIs compared with 1296 (31%) grants with a total value of £512 million (22%) awarded to female PIs. Male PIs received 1.3 times the median award value of their female counterparts (P<0.001). These apparent absolute and relative differences largely persisted regardless of subanalyses. CONCLUSIONS: We demonstrate substantial differences in cancer research investment awarded by gender. Female PIs clearly and consistently receive less funding than their male counterparts in terms of total investment, the number of funded awards, mean funding awarded and median funding awarded.
format Online
Article
Text
id pubmed-5931297
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59312972018-05-04 A systematic analysis of UK cancer research funding by gender of primary investigator Zhou, Charlie D Head, Michael G Marshall, Dominic C Gilbert, Barnabas J El-Harasis, Majd A Raine, Rosalind O’Connor, Henrietta Atun, Rifat Maruthappu, Mahiben BMJ Open Health Policy OBJECTIVES: To categorically describe cancer research funding in the UK by gender of primary investigator (PIs). DESIGN: Systematic analysis of all open-access data. METHODS: Data about public and philanthropic cancer research funding awarded to UK institutions between 2000 and 2013 were obtained from several sources. Fold differences were used to compare total investment, award number, mean and median award value between male and female PIs. Mann-Whitney U tests were performed to determine statistically significant associations between PI gender and median grant value. RESULTS: Of the studies included in our analysis, 2890 (69%) grants with a total value of £1.82 billion (78%) were awarded to male PIs compared with 1296 (31%) grants with a total value of £512 million (22%) awarded to female PIs. Male PIs received 1.3 times the median award value of their female counterparts (P<0.001). These apparent absolute and relative differences largely persisted regardless of subanalyses. CONCLUSIONS: We demonstrate substantial differences in cancer research investment awarded by gender. Female PIs clearly and consistently receive less funding than their male counterparts in terms of total investment, the number of funded awards, mean funding awarded and median funding awarded. BMJ Publishing Group 2018-04-30 /pmc/articles/PMC5931297/ /pubmed/29712689 http://dx.doi.org/10.1136/bmjopen-2017-018625 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Health Policy
Zhou, Charlie D
Head, Michael G
Marshall, Dominic C
Gilbert, Barnabas J
El-Harasis, Majd A
Raine, Rosalind
O’Connor, Henrietta
Atun, Rifat
Maruthappu, Mahiben
A systematic analysis of UK cancer research funding by gender of primary investigator
title A systematic analysis of UK cancer research funding by gender of primary investigator
title_full A systematic analysis of UK cancer research funding by gender of primary investigator
title_fullStr A systematic analysis of UK cancer research funding by gender of primary investigator
title_full_unstemmed A systematic analysis of UK cancer research funding by gender of primary investigator
title_short A systematic analysis of UK cancer research funding by gender of primary investigator
title_sort systematic analysis of uk cancer research funding by gender of primary investigator
topic Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931297/
https://www.ncbi.nlm.nih.gov/pubmed/29712689
http://dx.doi.org/10.1136/bmjopen-2017-018625
work_keys_str_mv AT zhoucharlied asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT headmichaelg asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT marshalldominicc asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT gilbertbarnabasj asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT elharasismajda asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT rainerosalind asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT oconnorhenrietta asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT atunrifat asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT maruthappumahiben asystematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT zhoucharlied systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT headmichaelg systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT marshalldominicc systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT gilbertbarnabasj systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT elharasismajda systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT rainerosalind systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT oconnorhenrietta systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT atunrifat systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator
AT maruthappumahiben systematicanalysisofukcancerresearchfundingbygenderofprimaryinvestigator